https://www.taxtmi.com/news?id=54214 The document addresses proposed import tariffs on pharmaceuticals, explaining that authorities may use Section 232 national-security powers to impose duties, with phased implementation to allow stockpiling. It warns tariffs would raise consumer prices, disrupt global supply chains, and disproportionately harm low-margin generic manufacturers, while noting branded firms may better absorb costs and that reshoring production is costly without targeted government support or exemptions. en-us Mon, 01 Sep 2025 14:46:03 +0530 Mon, 01 Sep 2025 14:46:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=54214 The document addresses proposed import tariffs on pharmaceuticals, explaining that authorities may use Section 232 national-security powers to impose duties, with phased implementation to allow stockpiling. It warns tariffs would raise consumer prices, disrupt global supply chains, and disproportionately harm low-margin generic manufacturers, while noting branded firms may better absorb costs and that reshoring production is costly without targeted government support or exemptions. News - Mon, 01 Sep 2025 14:46:03 +0530 https://www.taxtmi.com/news?id=54214